Viral clostridial light chain gene-based control of penicillin-induced neocortical seizures.

Abstract : Restraining excitatory neurotransmission within a seizure focus provides a nondestructive treatment strategy for intractable neocortical epilepsy. Clostridial toxin light chain (LC) inhibits synaptic transmission by digesting a critical vesicle-docking protein, synaptobrevin, without directly altering neuronal health. This study tests the treatment efficacy of adenoviral vector delivered LC (AdLC) on a model of seizures in rats induced by motor cortex penicillin (PCN) injection. LC expression significantly reduced electroencephalogram (EEG) frequency, amplitude, duration, and latency compared to control groups injected with either an adenoviral vector bearing green fluorescent protein (AdGFP) or phosphate buffered solution (PBS). Correspondingly, LC gene expression improved behavioral manifestations including seizure severity and latency. There was no statistical difference in motor function before and after vector administration between treatment and control groups. Histological analysis revealed spatially discrete LC expression with corresponding synaptobrevin depletion in the cortex surrounding the injection site. Thus, vector-mediated LC gene delivery is capable of improving both the EEG and behavioral manifestations of PCN-induced focal neocortical seizures through synaptobrevin depletion.
Type de document :
Article dans une revue
Molecular Therapy, Nature Publishing Group, 2007, 15 (3), pp.542-51. 〈10.1038/sj.mt.6300069〉
Liste complète des métadonnées

http://www.hal.inserm.fr/inserm-00383828
Contributeur : Jean-Paul Issartel <>
Soumis le : mercredi 13 mai 2009 - 16:00:40
Dernière modification le : jeudi 14 mai 2009 - 15:03:49

Lien texte intégral

Identifiants

Collections

Citation

Jun Yang, Qingshan Teng, Thais Federici, Imad Najm, Stephan Chabardes, et al.. Viral clostridial light chain gene-based control of penicillin-induced neocortical seizures.. Molecular Therapy, Nature Publishing Group, 2007, 15 (3), pp.542-51. 〈10.1038/sj.mt.6300069〉. 〈inserm-00383828〉

Partager

Métriques

Consultations de la notice

34